Market Research Report

A quick peek into the report

Global Reproductive Genetics Market

Focus on Procedure Type, Product Type, Technology, Application Type, Country Data (15 countries) - Analysis and Forecast, 2020-2030

Some Faq's

Frequently Asked Questions

In 2020, the global reproductive genetics market generated $4.40 billion and is projected to reach the mark of $12.93 billion by 2030.

Factors such as the declining cost of genetic sequencing technologies, increasing awareness and acceptance for genetic testing and screening, rising emphasis on early detection and prevention, and rising maternal age leading to pregnancy complications, favour the growth of this emerging tech. 

Lack of regulations and, ethical and social issues, are some challenges that hinder the adoption of reproductive genetics by healthcare institutions/companies.

Based on region, North America dominates the global reproductive genetics industry due to improved healthcare infrastructure, rise in awareness, and improvised reimbursement policies in the region. 

Major players involved in the reproductive genetics market are Illumina, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Natera, Inc., BGI, CooperSurgical, Inc., Centogene AG.

Similar Product

You may also like

Global Non-Invasive Prenatal Testing (NIPT) Market
Published Year: 2021

Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Test, Platform, End User, Appli

The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61...

Global Carrier Screening Market – Analysis and Forecast, 2019-2029
Published Year: 2019

Global Carrier Screening Market – Analysis and Forecast, 2019-2029: Focus on Product Type, Technol

The global carrier screening market was valued at $846.9 million in 2018 and is estimated to...